Patent · US Active

Human binding molecules having killing activity against enterococci and uses thereof

US7960518B2 · kind B2 · utility

39Cited by

5References

11Claims

0Family size

Assignee

Crucell Holland B.V. · NL

Inventors

Mark Throsby · Utrecht, NL
Robert A. Kramer · Crown Point, US
Cornelis Adriaan De Kruif · De Bilt, NL

Key dates

Filing date	Jun 5, 2007
Grant date	Jun 14, 2011
Priority date	—
Expiry date	Jun 5, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/21
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides human binding molecules specifically binding to enterococci and having killing activity against enterococci, nucleic acid molecules encoding the human binding molecules, compositions comprising the human binding molecules and methods of identifying or producing the human binding molecules. The human binding molecules can be used in the diagnosis, prophylaxis and/or treatment of a condition resulting from Enterococcus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.